S

Shin Nippon Biomedical Laboratories Ltd
TSE:2395

Watchlist Manager
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Watchlist
Price: 1 553 JPY -0.38% Market Closed
Market Cap: ¥64.7B

Wall Street
Price Targets

Price Targets Summary
Shin Nippon Biomedical Laboratories Ltd

Wall Street analysts forecast Shin Nippon Biomedical Laboratories Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shin Nippon Biomedical Laboratories Ltd is 2 641.8 JPY with a low forecast of 1 797.8 JPY and a high forecast of 3 570 JPY.

Lowest
Price Target
1 797.8 JPY
16% Upside
Average
Price Target
2 641.8 JPY
70% Upside
Highest
Price Target
3 570 JPY
130% Upside
Shin Nippon Biomedical Laboratories Ltd Competitors:
Price Targets

Revenue
Forecast

6% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
6% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Shin Nippon Biomedical Laboratories Ltd's revenue is 6%. The projected CAGR for the next 3 years is 7%.

Operating Income
Forecast

N/A
Past Growth
4 577% / Year
Estimated Growth
Estimates Accuracy
-100%
Average Miss
N/A
Past Growth
4 577% / Year
Estimated Growth
Estimates Accuracy
-100%
Average Miss

The compound annual growth rate of Shin Nippon Biomedical Laboratories Ltd's operating income for the next 2 years is 4 577%.

Net Income
Forecast

N/A
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
16%
Average Beat
N/A
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
16%
Average Beat

The compound annual growth rate of Shin Nippon Biomedical Laboratories Ltd's net income for the next 3 years is 4%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shin Nippon Biomedical Laboratories Ltd's stock price target?
Price Target
2 641.8 JPY

According to Wall Street analysts, the average 1-year price target for Shin Nippon Biomedical Laboratories Ltd is 2 641.8 JPY with a low forecast of 1 797.8 JPY and a high forecast of 3 570 JPY.

What is Shin Nippon Biomedical Laboratories Ltd's Revenue forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Shin Nippon Biomedical Laboratories Ltd's revenue is 6%. The projected CAGR for the next 3 years is 7%.

What is Shin Nippon Biomedical Laboratories Ltd's Operating Income forecast?
Projected CAGR
4 577%

The compound annual growth rate of Shin Nippon Biomedical Laboratories Ltd's operating income for the next 2 years is 4 577%.

What is Shin Nippon Biomedical Laboratories Ltd's Net Income forecast?
Projected CAGR
4%

The compound annual growth rate of Shin Nippon Biomedical Laboratories Ltd's net income for the next 3 years is 4%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett